Peptide Initiative

Peptides · Peptide comparison

Noopept (Omberacetam) vs Semax

Ultra-potent dipeptide nootropic and prodrug of cycloprolylglycine that enhances cognition through BDNF/NGF upregulation, AMPA receptor modulation, and multicomponent neuroprotection at doses 1000 times lower than piracetam

A brain-boosting peptide that supercharges your cognitive function by ramping up BDNF—the protein your neurons need to grow, connect, and stay sharp—all delivered through a simple nasal spray.

  • Cognitive
  • Cognitive

At a glance

Quick comparison

Dose rangeNoopept (Omberacetam)10–10 mgSemax500–900 mcg/day
FrequencyNoopept (Omberacetam)Multiple times dailySemaxOnce daily
AdministrationNoopept (Omberacetam)Oral (tablet/capsule)SemaxIntranasal spray
Cycle lengthNoopept (Omberacetam)12+ weeksSemax4-6 weeks
Onset speedNoopept (Omberacetam)Rapid (hours to days)SemaxRapid (hours to days)
Evidence levelNoopept (Omberacetam)Limited human trialsSemaxModerate human trials (Phase 1-2)

Efficacy

Benefit ratings

Memory & Learning

Noopept (Omberacetam)94%
SemaxNo recorded rating

Brain Protection

Noopept (Omberacetam)91%
SemaxNo recorded rating

Mental Clarity

Noopept (Omberacetam)86%
SemaxNo recorded rating

Cognitive Enhancement

Noopept (Omberacetam)No recorded rating
Semax94%

Neuroprotection

Noopept (Omberacetam)No recorded rating
Semax91%

Mental Energy

Noopept (Omberacetam)No recorded rating
Semax87%

Technical data

Compound specifications

Noopept (Omberacetam)

Molecular formula
C17H22N2O4
Molecular weight
318.4 g/mol
Half-life
Short plasma half-life (minutes); rapidly converted to active metabolite cycloprolylglycine which has a longer pharmacological duration; effects persist for hours after dosing
Bioavailability
Orally bioavailable with BBB penetration; metabolized to active cycloprolylglycine; approximately 1000-fold more potent than parent compound piracetam
CAS number
157115-85-0

Semax

Molecular formula
C37H51N9O10S
Molecular weight
813.9 g/mol
Half-life
Several minutes to hours (intranasal effects persist longer)
Bioavailability
High via intranasal route (directly reaches brain)
CAS number
80714-61-0

Protocols

Dosing compared

Noopept (Omberacetam)

Oral

  • 10 mg twice daily (20 mg/day)Twice daily (morning and afternoon) · 56 days (8 weeks) per clinical studyDose used in a controlled human study of mild cognitive impairment, improving cognition with good tolerability [6].

Semax

Intranasal

  • 250-500 mcg/dayOnce or twice daily · 1-2 weeksCognitive/nootropic practice with the 0.1% solution; downstream BDNF/NGF effects persist 12-24 h so dosing is once to twice daily [1][2].
  • 500-900 mcg/dayDivided 2-3 times daily · 3-4 weeksMid-range nootropic practice dose; upregulates hippocampal BDNF/TrkB in animal models [1][2][3].

Applications

Best suited for

Noopept (Omberacetam)

Cognitive enhancement for learning, memory formation, and information retrieval
Noopept (Omberacetam) is particularly well-suited for individuals focused on cognitive enhancement for learning, memory formation, and information retrieval. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Neuroprotection against oxidative stress and age-related cognitive decline
Noopept (Omberacetam) is particularly well-suited for individuals focused on neuroprotection against oxidative stress and age-related cognitive decline. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Nootropic stacking — complements racetams, cholinergics, and neurotrophic peptides through distinct mechanisms
Noopept (Omberacetam) is particularly well-suited for individuals focused on nootropic stacking — complements racetams, cholinergics, and neurotrophic peptides through distinct mechanisms. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Support during periods of intense intellectual work or study
Noopept (Omberacetam) is particularly well-suited for individuals focused on support during periods of intense intellectual work or study. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Semax

Students and Knowledge Workers
If your day revolves around learning, studying, or processing complex information, Semax can be a game-changer. It enhances memory consolidation and recall while improving your ability to focus for extended periods—perfect for exam prep or demanding projects [6][12].
Those Seeking Mental Clarity
Brain fog? Semax works by boosting BDNF—the protein that helps neurons communicate effectively. [1][2] Users often report feeling like the 'mental static' clears away, leaving sharper, more efficient thinking in its place.
Neuroprotection Seekers
Beyond immediate cognitive benefits, Semax offers protective effects for your brain cells. [9] It acts as an antioxidant (especially against copper toxicity) [4][8] and supports neuronal health—valuable for anyone concerned about long-term brain wellness.
Recovery Support (Under Medical Supervision)
In Russia, Semax is approved for helping stroke patients and those with traumatic brain injuries recover cognitive function. [6] While not FDA-approved for this use elsewhere, the research shows meaningful neuroprotective and neurorestorative properties [7][9].

Safety profile

Side effects

Noopept (Omberacetam)

Common

  • Headache
  • Irritability or restlessness
  • Sleep disturbance
  • Mild gastrointestinal discomfort
  • Vivid dreams

Uncommon

  • Blood pressure increase

Serious

  • Allergic reaction

Semax

Common

  • Nasal irritation
  • Mild headache
  • Increased alertness

Uncommon

  • Temporary blood pressure increase
  • Dizziness

Serious

  • Allergic reaction

Research status

Safety & evidence

Noopept (Omberacetam)

Evidence level
Limited human trials
FDA status
Research compound
Safety overview
Noopept demonstrates excellent safety in Russian clinical trials with LD50 >2000 mg/kg (oral, rats)—approximately 100 times higher than therapeutic doses. No serious adverse events reported in human studies up to 30 mg/day for 6-12 weeks. Mild side effects (headache, irritability) occur in <5% of users and resolve with dose reduction. No carcinogenicity, mutagenicity, or teratogenicity in preclinical testing; minimal drug interactions due to lack of hepatic CYP450 metabolism.

Contraindications

  • Known hypersensitivity to Noopept, piracetam, or other racetam-class compounds
  • Pregnancy and breastfeeding — insufficient safety data
  • Severe hepatic impairment — Noopept undergoes hepatic metabolism
  • Severe renal impairment — metabolites are renally excreted
  • Lactose intolerance (some tablet formulations contain lactose as excipient)

Semax

Evidence level
Moderate human trials (Phase 1-2)
FDA status
Research compound
Safety overview
Semax has been used clinically in Russia for over 25 years with an excellent safety profile. [7][12] It's approved there for treating stroke, cognitive impairment, and optic nerve diseases. [6] Studies consistently show minimal side effects, mostly limited to mild nasal irritation when using the spray form. [6][9] Unlike stimulants, Semax doesn't appear to cause tolerance, dependence, or withdrawal symptoms even with extended use.

Contraindications

  • Pregnancy or planning to become pregnant
  • Currently breastfeeding
  • History of seizures or epilepsy
  • Known allergy to ACTH-related peptides
  • Uncontrolled hypertension

Decision guide

Which is right for you?

Noopept (Omberacetam)

Choose Noopept (Omberacetam) if…

  • Cognitive enhancement for learning, memory formation, and information retrieval
  • Neuroprotection against oxidative stress and age-related cognitive decline
  • Nootropic stacking — complements racetams, cholinergics, and neurotrophic peptides through distinct mechanisms
  • Support during periods of intense intellectual work or study

Semax

Choose Semax if…

  • Cognitive enhancement
  • Memory improvement
  • Focus and concentration
  • Neuroprotection